Based on these observations, it has been proposed that connections between the loss of CFTR, reduced ASL pH, and impaired CF host defense function could provide a paradigm for the identification of new therapeutic targets and strategies to reduce the morbidity associated with CF lung disease [165]. The gene discussed is CFTR; the disease is cystic fibrosis.